The club bought into Heckmann Corporation at a commission adjusted cost of $4.59. We are excited to add Heckmann to the EP Club portfolio and look forward to expected growth in the industry.
Heckmann Corporation, together with its subsidiaries, is a services-based company focused on total water solutions for shale or unconventional oil and gas exploration. The Company operates in water solutions for energy development segment. Its water solutions for energy development segment include Heckman Water Resources (HWR). HWR’s services include water delivery and disposal, trucking, fluids handling, treatment and temporary and permanent pipeline facilities, and water infrastructure services for oil and gas exploration and production companies. HWR also transports fresh water for production and provides services for site preparation, water pit excavations and remediation. HWR operates multi-modal water disposal, treatment, trucking and pipeline transportation operations in select shale areas in the United States in the Haynesville, Eagle Ford, Marcellus/Utica and Barnett shale plays.
The club also bought into Omeros Corporation at a commission adjusted cost of $10.58. We are also excited to add Omeros to our portfolio and look forward to seeing the progress in gene sequencing.
Omeros Corporation, incorporated on June 16, 1994, is a clinical-stage biopharmaceutical company. It is engaged in discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system. Its product candidates are derived from its PharmacoSurgerytm platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Its PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to preemptively inhibit inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery.. The Company has six ongoing clinical development programs, including four from its PharmacoSurgery platform and two from its Addiction franchise.